Oxaliplatin salvage for recurrent ovarian cancer: a single institution's experience in patient populations with platinum resistant disease or a history of platinum hypersensitivity.

Taylor, Sarah E; Beck, Tiffany L; Krivak, Thomas C; Zorn, Kristin K; Kelley, Joseph L; Edwards, Robert P

Taylor, Sarah E; Beck, Tiffany L; Krivak, Thomas C; Zorn, Kristin K; Kelley, Joseph L; Edwards, Robert P.

Affiliation

Taylor SE; Department of Obstetrics Gynecology, Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. Electronic address: taylorse2@mail.magee.edu.
Beck TL; Department of Obstetrics Gynecology, Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Krivak TC; Department of Obstetrics Gynecology, Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Zorn KK; Department of Obstetrics Gynecology, Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Kelley JL; Department of Obstetrics Gynecology, Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Edwards RP; Department of Obstetrics Gynecology, Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Gynecol Oncol ; 134(1): 68-72, 2014 Jul.

Article in En | MEDLINE | ID: mdl-24769036

Subject(s)
Key words

Ovarian cancer; Platinum hypersensitivity; Salvage

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organoplatinum Compounds / Ovarian Neoplasms / Neoplasms, Glandular and Epithelial / Antineoplastic Agents Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Gynecol Oncol Year: 2014 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google